169 related articles for article (PubMed ID: 21907426)
1. The role of adiponectin in human vascular physiology.
Vaiopoulos AG; Marinou K; Christodoulides C; Koutsilieris M
Int J Cardiol; 2012 Mar; 155(2):188-93. PubMed ID: 21907426
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.
Nishimura M; Izumiya Y; Higuchi A; Shibata R; Qiu J; Kudo C; Shin HK; Moskowitz MA; Ouchi N
Circulation; 2008 Jan; 117(2):216-23. PubMed ID: 18158361
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin: anti-inflammatory and cardioprotective effects.
Villarreal-Molina MT; Antuna-Puente B
Biochimie; 2012 Oct; 94(10):2143-9. PubMed ID: 22796520
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular actions of adiponectin: pathophysiologic implications.
Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between adipose tissue and vasculature: role of adiponectin.
Li FY; Cheng KK; Lam KS; Vanhoutte PM; Xu A
Acta Physiol (Oxf); 2011 Sep; 203(1):167-80. PubMed ID: 21062420
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin resistance and vascular dysfunction in the hyperlipidemic state.
Li R; Lau WB; Ma XL
Acta Pharmacol Sin; 2010 Oct; 31(10):1258-66. PubMed ID: 20802503
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin as an anti-inflammatory factor.
Ouchi N; Walsh K
Clin Chim Acta; 2007 May; 380(1-2):24-30. PubMed ID: 17343838
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin and cardiovascular disease: response to therapeutic interventions.
Han SH; Quon MJ; Kim JA; Koh KK
J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
[TBL] [Abstract][Full Text] [Related]
10. Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling.
Pei H; Qu Y; Lu X; Yu Q; Lian K; Liu P; Yan W; Liu J; Ma Y; Liu Y; Li C; Li W; Lau WB; Zhang H; Tao L
Basic Res Cardiol; 2013 Jan; 108(1):322. PubMed ID: 23262803
[TBL] [Abstract][Full Text] [Related]
11. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
Matsuda M; Shimomura I
Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin actions in the cardiovascular system.
Hopkins TA; Ouchi N; Shibata R; Walsh K
Cardiovasc Res; 2007 Apr; 74(1):11-8. PubMed ID: 17140553
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory and anti-atherogenic properties of adiponectin.
Ohashi K; Ouchi N; Matsuzawa Y
Biochimie; 2012 Oct; 94(10):2137-42. PubMed ID: 22713764
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin: an update.
Guerre-Millo M
Diabetes Metab; 2008 Feb; 34(1):12-8. PubMed ID: 18069030
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin and hypertension.
Ohashi K; Ouchi N; Matsuzawa Y
Am J Hypertens; 2011 Mar; 24(3):263-9. PubMed ID: 20930707
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin enhances osteogenic differentiation in human adipose-derived stem cells by activating the APPL1-AMPK signaling pathway.
Chen T; Wu YW; Lu H; Guo Y; Tang ZH
Biochem Biophys Res Commun; 2015 May; 461(2):237-42. PubMed ID: 25892517
[TBL] [Abstract][Full Text] [Related]
17. Adipokines identified as new downstream targets for adiponectin: lessons from adiponectin-overexpressing or -deficient mice.
Ge Q; Ryken L; Noel L; Maury E; Brichard SM
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E326-35. PubMed ID: 21540448
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity.
Katira A; Tan PH
Expert Opin Ther Targets; 2015; 19(8):1105-25. PubMed ID: 25952656
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin and interleukin-6 in inflammation-associated disease.
Li L; Wu LL
Vitam Horm; 2012; 90():375-95. PubMed ID: 23017723
[TBL] [Abstract][Full Text] [Related]
20. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies.
Han SH; Sakuma I; Shin EK; Koh KK
Prog Cardiovasc Dis; 2009; 52(2):126-40. PubMed ID: 19732605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
